FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2554064041> ?p ?o ?g. }

• W2554064041 endingPage "2246" @default.
• W2554064041 startingPage "2246" @default.
• W2554064041 abstract "Abstract A major type of drug-induced immune thrombocytopenia (DITP), characterized by an acute, sometimes life-threatening drop in platelets following drug exposure, is caused by a unique type of antibody that recognizes its target on a platelet membrane glycoprotein, usually αIIb/β3 integrin [glycoprotein (GP) IIb/IIIa], only when the sensitizing drug is present in soluble form. Quinine (Qn) is the prototypic drug that causes this complication, but many other drugs have been implicated. It is widely thought that drug-dependent, platelet-reactive antibodies (DDAbs) characteristic of DITP recognize drug-induced structural modifications of platelet glycoproteins (GP), but this has not been confirmed experimentally. The mechanism responsible for DDAb binding is difficult to study with human DDAbs, which are often poly-specific and in short supply. We used newly-developed, Qn-dependent monoclonal antibodies (IgG1 mAbs 314.1, 314.3) that recognize the N-terminus of GPIIb and closely mimic the serologic behavior of antibodies from patients with Qn-induced immune thrombocytopenia (Blood 2009; 113;1105-11) as an alternative tool for studying the molecular basis of drug-dependent antibody binding. Previous studies failed to demonstrate a docking site for Qn in domains of GPIIb/IIIa that are known targets for the 314 mAbs and for human Qn-dependent antibodies. Therefore we examined an alternative possibility - that binding of drug to antibody might be the first step in DDAb binding. For this purpose, Qn was perfused over the 314 mAbs immobilized on Biacore chips and surface plasmon resonance (SPR) signals were recorded. Findings showed that Qn binds specifically to both mAbs with high affinity (Kd about 30 nM) and with 2:1 stoichiometry (Qn to mAb), consistent with recognition of Qn by complementarity determining regions (CDR) of the mAbs. To characterize monovalent binding of mAb to GPIIb/IIIa, purified integrin in 0.1% triton X-100 was perfused over immobilized mAb 314.1 and SPR signals recorded. Weak, but specific binding was observed in the absence of Qn (Kd 11 uM) that was enhanced 5-fold (Kd 2.2 uM) when Qn was present. Kds for Qn-dependent binding of mAb 314.1 (bivalent interaction) and its Fab fragment (monovalent interaction) to GPIIb/IIIa were determined by flow cytometry using labeled antibody and Fab under conditions that did not require washing prior to direct measurement of platelet bound IgG and Fab. Weak Fab binding was observed in the presence of Qn (≈19 uM) but with intact IgG the effective Kd was reduced to 0.15 nM, reflecting a 100,000-fold increase in avidity. Together with studies that have failed to demonstrate any docking site for Qn on GPIIb/IIIa, the findings support a model in which DDAb-GPIIb/IIIa interaction starts with binding of drug to the antibody CDR, leading to a structural change that markedly increases the avidity of antibody for a weak autoantigen. A requirement for bivalent antibody-target interaction to achieve tight binding could explain why DDAbs almost invariably recognize GPIIb/IIIa or GPIb/IX, the most highly expressed platelet glycoproteins. How this type of DDAb is induced by drug remains uncertain but the findings are consistent with a model in which sensitization starts with drug-induced modification of a B cell receptor that increases its affinity for a weak autoantigen. Disclosures Aster: BLOODCENTER OF WISCONSIN: Patents & Royalties: A patent application has been filed based partly on these findings (Method of detecting platelet activating antibodies that cause heparin-induced thrombocytopenia/thrombosis; PCT/US14/62591)." @default.
• W2554064041 created "2016-11-30" @default.
• W2554064041 creator A5014209265 @default.
• W2554064041 creator A5031096218 @default.
• W2554064041 creator A5052000553 @default.
• W2554064041 creator A5071951242 @default.
• W2554064041 date "2015-12-03" @default.
• W2554064041 modified "2023-09-27" @default.
• W2554064041 title "Binding of Quinine-Dependent Monoclonal Antibodies to Gpiib/Iiia Appears to Involve Drug-Induced Modulation of Antibody Affinity" @default.
• W2554064041 doi "https://doi.org/10.1182/blood.v126.23.2246.2246" @default.
• W2554064041 hasPublicationYear "2015" @default.
• W2554064041 type Work @default.
• W2554064041 sameAs 2554064041 @default.
• W2554064041 citedByCount "0" @default.
• W2554064041 crossrefType "journal-article" @default.
• W2554064041 hasAuthorship W2554064041A5014209265 @default.
• W2554064041 hasAuthorship W2554064041A5031096218 @default.
• W2554064041 hasAuthorship W2554064041A5052000553 @default.
• W2554064041 hasAuthorship W2554064041A5071951242 @default.
• W2554064041 hasConcept C153911025 @default.
• W2554064041 hasConcept C159654299 @default.
• W2554064041 hasConcept C170493617 @default.
• W2554064041 hasConcept C185592680 @default.
• W2554064041 hasConcept C195687474 @default.
• W2554064041 hasConcept C203014093 @default.
• W2554064041 hasConcept C2780035454 @default.
• W2554064041 hasConcept C2910542480 @default.
• W2554064041 hasConcept C542903549 @default.
• W2554064041 hasConcept C55493867 @default.
• W2554064041 hasConcept C86803240 @default.
• W2554064041 hasConcept C89560881 @default.
• W2554064041 hasConcept C98274493 @default.
• W2554064041 hasConceptScore W2554064041C153911025 @default.
• W2554064041 hasConceptScore W2554064041C159654299 @default.
• W2554064041 hasConceptScore W2554064041C170493617 @default.
• W2554064041 hasConceptScore W2554064041C185592680 @default.
• W2554064041 hasConceptScore W2554064041C195687474 @default.
• W2554064041 hasConceptScore W2554064041C203014093 @default.
• W2554064041 hasConceptScore W2554064041C2780035454 @default.
• W2554064041 hasConceptScore W2554064041C2910542480 @default.
• W2554064041 hasConceptScore W2554064041C542903549 @default.
• W2554064041 hasConceptScore W2554064041C55493867 @default.
• W2554064041 hasConceptScore W2554064041C86803240 @default.
• W2554064041 hasConceptScore W2554064041C89560881 @default.
• W2554064041 hasConceptScore W2554064041C98274493 @default.
• W2554064041 hasIssue "23" @default.
• W2554064041 hasLocation W25540640411 @default.
• W2554064041 hasOpenAccess W2554064041 @default.
• W2554064041 hasPrimaryLocation W25540640411 @default.
• W2554064041 hasRelatedWork W1521861424 @default.
• W2554064041 hasRelatedWork W1531658016 @default.
• W2554064041 hasRelatedWork W1548240869 @default.
• W2554064041 hasRelatedWork W1656991593 @default.
• W2554064041 hasRelatedWork W1863318531 @default.
• W2554064041 hasRelatedWork W1999448311 @default.
• W2554064041 hasRelatedWork W2000335206 @default.
• W2554064041 hasRelatedWork W2014743914 @default.
• W2554064041 hasRelatedWork W2042894336 @default.
• W2554064041 hasRelatedWork W2063223500 @default.
• W2554064041 hasRelatedWork W2070645153 @default.
• W2554064041 hasRelatedWork W2093705679 @default.
• W2554064041 hasRelatedWork W2402519077 @default.
• W2554064041 hasRelatedWork W2418808623 @default.
• W2554064041 hasRelatedWork W2440076245 @default.
• W2554064041 hasRelatedWork W2520524386 @default.
• W2554064041 hasRelatedWork W2586215326 @default.
• W2554064041 hasRelatedWork W2789250020 @default.
• W2554064041 hasRelatedWork W2948545859 @default.
• W2554064041 hasRelatedWork W2989030769 @default.
• W2554064041 hasVolume "126" @default.
• W2554064041 isParatext "false" @default.
• W2554064041 isRetracted "false" @default.
• W2554064041 magId "2554064041" @default.
• W2554064041 workType "article" @default.